FEC Monitor

Donors — Filing 1948968

Gilead Sciences Inc Healthcare Policy PAC (C00396895) · F3X M2 · 2026-01-01 → 2026-01-31 · .fec · back to dashboard

39 donorss.

Date Contributor Type Employer Occupation Amount
2026-01-30 Jyoti Mehra IND Gilead Sciences, Inc. EVP, Human Resources $1,000.00
2026-01-26 Scott Regdos IND Gilead Sciences, Inc. Sr Manager, Commercial L&D $1,000.00
2026-01-23 Manendiu Anne Bazile IND Gilead Sciences, Inc. Exec Director, Government Affairs $192.30
2026-01-23 Michael David Boyd IND Gilead Sciences, Inc. SVP, Government Affairs & Policy $192.30
2026-01-23 Nitiya M Brooks IND Gilead Sciences, Inc. Director, Sales $192.30
2026-01-23 Keeley M Cain Wettan IND Gilead Sciences, Inc. EVP, General Counsel, Legal & Complian $192.30
2026-01-23 Scott Wolff IND Kite Pharma, Inc. Director, Operational Excellence $192.30
2026-01-23 Jared Baeten IND Gilead Sciences, Inc. SVP, Virology $192.30
2026-01-23 Aquarius Gilmer IND Gilead Sciences, Inc. Sr Senior Director, Business Strategy $192.30
2026-01-23 Anna Griffin IND Gilead Sciences, Inc. Exec Director, Government Affairs $192.30
2026-01-23 Julia Griffiths IND Gilead Sciences, Inc. Sr Director, Marketing $192.30
2026-01-23 Brian Heath IND Kite Pharma, Inc. SVP, Kite Commercial $192.30
2026-01-23 Kristina Hermach IND Gilead Sciences, Inc. Sr Director, Government Affairs $192.30
2026-01-23 Linda S Higgins IND Gilead Sciences, Inc. SVP, Research Strategy, Innovation & P $192.30
2026-01-23 Shreya Jani IND Gilead Sciences, Inc. SVP, Public Affairs $192.30
2026-01-23 Flavius Martin IND Gilead Sciences, Inc. EVP, Research $192.30
2026-01-23 Tony Leon Mitchell Jr. IND Gilead Sciences, Inc. Sr Director, Government Affairs $192.30
2026-01-23 Daniel O'Day IND Gilead Sciences, Inc. Chairman & CEO $192.30
2026-01-23 Joseph Spiegler IND Kite Pharma, Inc. VP, Kite Legal $192.30
2026-01-23 James G Taylor IND Gilead Sciences, Inc. SVP, Research Small Molecule Drug Disc $192.30
2026-01-23 Camille M Alexander IND Gilead Sciences, Inc. VP, Total Rewards $192.30
2026-01-23 Tomas Cihlar IND Gilead Sciences, Inc. SVP, Research Virology $192.30
2026-01-23 Charles Clapton IND Gilead Sciences, Inc. VP, Government Affairs $192.30
2026-01-23 James Class IND Gilead Sciences, Inc. Exec Director, Policy $192.30
2026-01-23 Kevin Cognetti IND Kite Pharma, Inc. Kite VP, Corporate Development & Strat $192.30
2026-01-23 Andrew D Dickinson IND Gilead Sciences, Inc. EVP, Chief Financial Officer $192.30
2026-01-23 Nathaniel Sillin IND Gilead Sciences, Inc. Sr Director, Public Affairs $185.00
2026-01-23 Anuoluwapo O Osinusi IND Gilead Sciences, Inc. VP, Clinical Development, Virology $175.00
2026-01-23 Janet Dorling IND Gilead Sciences, Inc. SVP, General Manager U.S. $150.00
2026-01-23 Cynthia Perettie IND Kite Pharma, Inc. EVP, Kite $150.00
2026-01-23 Kevin Cash IND Gilead Sciences, Inc. Sr Counsel I $150.00
2026-01-23 Carnley Norman IND Kite Pharma, Inc. Kite VP, Process Development $150.00
2026-01-23 Kieta D Mutepfa IND Gilead Sciences, Inc. Sr. Community Liaison $125.00
2026-01-23 James A. Kotusky IND Gilead Sciences, Inc. National Account Director $125.00
2026-01-23 William Bode IND Gilead Sciences, Inc. Sr Director, Government Affairs $125.00
2026-01-23 Jimmy Lee IND Gilead Sciences, Inc. VP, Sales & Marketing $120.00
2026-01-23 Grace Elizabeth Rodden IND Gilead Sciences, Inc. Exec Director, Government Affairs $104.00
2026-01-09 Jacqueline Hansen IND Gilead Sciences, Inc. Sr Therapeutic Specialist, Oncology $500.00
2026-01-08 Chan Chea IND Gilead Sciences, Inc. SVP, Tax $5,000.00